| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.085 | 0.2 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |